Off-market insider selling at Emerald Health Therapeuti (EMH)

Off-market insider selling at Emerald Health Therapeuti (V:EMH)

Updated Friday Jun 01, 2018 02:00 AM EDT
Emerald Health Sciences Inc., a 10% Holder, disposed of 2,000,000 Common Shares on a direct ownership basis at a price of $4.200 through a prospectus or prospectus exempt offering on May 22nd, 2018. This represents a $8,400,000 divestment of the company's shares and an account share holdings change of -4.4%.

Emerald Health Therapeuti is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.

Emerald Health Therapeutics Inc is a Canada-based company engaged in the medical marijuana industry. The Company operates through Emerald Health Botanicals Inc (Botanicals), a wholly owned subsidiary and Licensed Producer under Canada's Access to Cannabis for Medical Purposes Regulations. Through Botanicals, the Company is authorized to produce and sell dried cannabis flower and cannabis oil for medical purposes. The Company operates an indoor cultivation facility in Victoria, British Columbia and, through Pure Sunfarms Corp, a joint venture with Village Farms International Inc, expands into additional greenhouses. The Company also offers analytical testing of cannabis through an interest in Northern Vine Canada Inc, a Licensed Dealer under Canadian Controlled Drugs and Substances Act. The Company is part of the Emerald Health Group, which is focused on developing pharmaceutical, botanical and nutraceutical products designed to interact with the human body's endocannabinoid system.


Top